Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia
Aran Singanayagam1, Stefano Aliberti2,3, Catia Cillóniz4
1Dept of Respiratory Medicine, St. Mary's Hospital, Imperial College London, London, UK aransinga@gmail.com.
Abstract:
International guidelines including those in the UK, Japan, Australia and South Africa recommend the avoidance of macrolides in patients with low-severity community-acquired pneumonia (CAP). We hypothesised that severity scores are poor predictors of atypical pneumonia and response to macrolide therapy, and thus, inadequate tools for guiding antibiotic prescriptions.Secondary analysis of four independent prospective CAP datasets was conducted. The predictive values of the CURB-65 and pneumonia severity index (PSI) for clinically important groups of causative pathogens were evaluated. The effect of macrolide use according to risk class was assessed by multivariable analysis. Patients (3297) were evaluated, and the predictive values of CURB-65 and PSI for atypical pathogens were poor (AUC values of 0.37 and 0.42, respectively). No significant differences were noted among the effects of macrolide use on mortality in patients with mild, moderate and severe CAP, according to either CURB-65 (interaction testing severe versus mild disease OR=0.74 (0.29-1.89)) or PSI (severe versus mild disease OR=3.4 (0.055-2.10)), indicating that severity scores were not significant modifiers of response to macrolide therapy.Severity scores did not accurately predict response to macrolide therapy in CAP, suggesting that current guidance to use these tools for empirical antibiotic choices might not be justified.
Insights
Current guidelines suggest avoiding macrolides for mild community-acquired pneumonia (CAP). However, severity scores like CURB-65 and PSI poorly predict atypical pathogens and macrolide response in CAP patients.
Area of Science:
- Infectious Diseases
- Pulmonology
- Clinical Pharmacology
Background:
- International guidelines recommend against macrolide use in low-severity community-acquired pneumonia (CAP).
- This recommendation is based on the assumption that severity scores accurately predict pathogen type and treatment response.
- The efficacy of severity scores in guiding antibiotic selection for CAP remains questionable.
Purpose of the Study:
- To evaluate the predictive value of CURB-65 and pneumonia severity index (PSI) for atypical pathogens in CAP.
- To assess whether CAP severity scores modify the response to macrolide therapy.
- To determine if current guidelines for macrolide use in CAP are evidence-based.
Main Methods:
- Secondary analysis of four independent prospective CAP datasets.
- Evaluation of CURB-65 and PSI predictive values for causative pathogens using AUC.
- Multivariable analysis to assess macrolide treatment effects across different severity classes.
Main Results:
- CURB-65 and PSI showed poor predictive value for atypical pathogens (AUC 0.37 and 0.42, respectively).
- No significant differences in macrolide treatment effects on mortality were observed across mild, moderate, and severe CAP.
- Severity scores did not significantly modify the response to macrolide therapy.
Conclusions:
- Severity scores are inadequate for predicting atypical pneumonia or guiding macrolide therapy in CAP.
- Current international guidelines recommending macrolide avoidance based on severity scores may not be justified.
- Further research may be needed to refine antibiotic prescribing strategies for CAP.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:26Tonsillitis II: Management
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:18Endocarditis III: Medical Management